New York, USA – April 14, 2021 – Creative Bioarray, the innovative biotechnology products and services provider, focuses on developing unique technologies to accelerate the research in the field of biology, life science, and pharmaceutical etc. Recently, Creative Bioarray announced the release of its various tumor cell panels for cancer research and drug discovery.
Creative Bioarray provides a growing collection of human and animal cell lines that have undergone extensive viability, biological activity and mycoplasma testing to ensure strong and reproducible results. Creative Bioarray is committed to establishing proliferating cell lines with multiple advantages, including cost-effectiveness, ease of use, and bypassing the ethical considerations associated with the use of animal and human tissues. Cell lines have revolutionized scientific research and have been used for drug metabolism and cytotoxicity testing, antibody production, vaccine production, protein synthesis and gene function research.
In order to create powerful tools for cancer research and drug discovery, Creative Bioarray has launched a variety of tumor cell groups by integrating authenticated and well-characterized cell lines with mutation data from the Sanger Cancer Somatic Mutation Catalog (COSMIC). Each cell line has been validated by STR and tested for Mycoplasma, and is usually used in research projects with molecules of various sizes.
Creative Bioarray has launched tumor cell research groups based on the source of the tissue, and each group has published detailed information about known mutations, making tumor cell lines a more powerful research model and drug discovery tool. In addition, Creative Bioarray has created a variety of tumor cell lists based on the genetic mutation information in the Sanger Institute COSMIC database, so that researchers can make more informed choices when choosing a cell-based research model.
“Creative Bioarray provides a comprehensive range of cell lines for biomedical research. Our experienced research team focuses on providing a comprehensive characterization of cells.” said Hannah Cole, the marketing director of Creative Bioarray, she also added, “We produce the world’s most comprehensive list of research cells, including tumor cells, primary cells, stem cells and transformed cells. If you have special needs, we are capable to offer customized solutions to help accelerate your research progress.”
About Creative Bioarray
Founded in 2005, Creative Bioarray is dedicated to offering customers with innovative biotechnology products and services for research use to greatly enhance and drive innovation and standards in science. As a well-recognized industry leader with more than 10 years of experience and in-house experts supported, Creative Bioarray has already countenanced research all around the world.